Phase II treatment of adults with newly diagnosed, progressive or recurrent primary malignant anaplastic oligodendroglioma with Temodal

Trial Profile

Phase II treatment of adults with newly diagnosed, progressive or recurrent primary malignant anaplastic oligodendroglioma with Temodal

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2009

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2009 Actual end date (Feb 2001) added as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top